Skip to main content

Table 1 J10 shift analysis table from D15 to D85*

From: Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset

N (%) Disease State at Day 15* Disease state at Day 85*
   ID LDA MDA HDA
ID 28 (100) 24 (85.7) 1 (3.6) 3 (10.7) 0 (0.0)
LDA 20 (100) 10 (50.0) 10 (50.0) 0 (0.0) 0 (0.0)
MDA 30 (100) 5 (16.7) 12 (40.0) 10 (33.3) 3 (10.0)
HDA 44 (100) 2 (4.5) 6 (13.6) 8 (18.2) 28 (63.6)
  1. *Only patients with both a Day 15 and a Day 85 value are included